0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4114.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;313(17):1703. doi:10.1001/jama.2015.4098.

Viewpoint | 
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. 2015;313(16):1617-1618. doi:10.1001/jama.2015.2571.

Research Letter | 
Nicolas Stettler, MD, MSCE; Colleen M. McKiernan, MSPH; Court Q. Melin, BS; et al.
JAMA. 2015;313(16):1671-1672. doi:10.1001/jama.2015.3075.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(15):1507. doi:10.1001/jama.2015.3309.

Preliminary Communication | 
Salima Hacein-Bey Abina, PharmD, PhD; H. Bobby Gaspar, MRCP, PhD; Johanna Blondeau, MS; et al.
JAMA. 2015;313(15):1550-1563. doi:10.1001/jama.2015.3253.
Includes: Supplemental Content

Viewpoint | 
Anthony Atala, MD; Sean Murphy, PhD
JAMA. 2015;313(14):1413-1414. doi:10.1001/jama.2015.1492.

JAMA Diagnostic Test Interpretation | 
Meng Chen, MD; Tiffany Y. Kim, MD; Antonio M. Pessegueiro, MD
JAMA. 2015;313(8):849-850. doi:10.1001/jama.2014.14074.

Editorial | 
Howard L. McLeod, PharmD
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086.

Original Investigation | 
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Research Letter  | 
Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma
Pauline Laly, MD; Saskia Ingen-Housz-Oro, MD; Marie Beylot-Barry, MD, PhD; et al.
JAMA Neurology
Images in Neurology  | 
Leukemic Polyradiculopathy Due to Blastic Plasmacytoid Dendritic Cell Neoplasm
William F. Qubty, MD; Aref Al-Kali, MD; Lyell K. Jones Jr, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity:  Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis:  A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.